Trial intelligence / Profile preview

Dexmedetomidine vs remimazolam for postoperative sleep quality in elderly lumbar endoscopic surgery

ChiCTR2400091576Phase 4Not yet recruiting

Sponsor
Guangzhou Panyu District Central Hospital
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in sleep disorder comparing Remimazolam group with Dexmedetomidine group (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index (PSQI). Planned start Nov 2024; status: not yet recruiting.

02

Drugs

dexmedetomidineremimazolam
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2400091576.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400091576.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call